Notice of Intent to Sole Source – Intera 3000 Hepatic Artery Infusion Pumps (NIH/NCI)

The National Institutes of Health (NIH) intends to award a sole source contract to Inter Oncology Inc. for the procurement of Intera 3000 Hepatic Artery Infusion Pumps. The contract will have a base period of performance from April 6, 2026, to April 5, 2027, with option line items for additional pumps. The NIH requires these pumps to support an IRB-approved clinical protocol involving hepatic artery infusion therapy for oncology patients. • The contract will be a Firm-Fixed-Price contract action. • The period of performance associated with exercised options may be less than one year. • The acquisition is being conducted using simplified procedures for certain commercial products and commercial services under FAR Subpart 13.5. • The NAICS code for this opportunity is 339112 – Surgical and Medical Instrument Manufacturing.